135 related articles for article (PubMed ID: 11006125)
1. Neuroendocrine-specific protein C, a marker of neuronal differentiation, is reduced in brain of patients with Down syndrome and Alzheimer's disease.
Kim SH; Yoo BC; Broers JL; Cairns N; Lubec G
Biochem Biophys Res Commun; 2000 Sep; 276(1):329-34. PubMed ID: 11006125
[TBL] [Abstract][Full Text] [Related]
2. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.
Greber S; Lubec G; Cairns N; Fountoulakis M
Electrophoresis; 1999; 20(4-5):928-34. PubMed ID: 10344268
[TBL] [Abstract][Full Text] [Related]
3. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.
Yoo BC; Fountoulakis M; Cairns N; Lubec G
Electrophoresis; 2001 Jan; 22(1):172-9. PubMed ID: 11197169
[TBL] [Abstract][Full Text] [Related]
4. Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease.
Lumbreras M; Baamonde C; Martínez-Cué C; Lubec G; Cairns N; Sallés J; Dierssen M; Flórez J
Amino Acids; 2006 Nov; 31(4):449-56. PubMed ID: 16583316
[TBL] [Abstract][Full Text] [Related]
5. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.
Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M
Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246
[TBL] [Abstract][Full Text] [Related]
6. The unfolded protein response affects neuronal cell cycle protein expression: implications for Alzheimer's disease pathogenesis.
Hoozemans JJ; Stieler J; van Haastert ES; Veerhuis R; Rozemuller AJ; Baas F; Eikelenboom P; Arendt T; Scheper W
Exp Gerontol; 2006 Apr; 41(4):380-6. PubMed ID: 16564150
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of molecular chaperones in brain of patients with Down syndrome.
Yoo BC; Vlkolinsky R; Engidawork E; Cairns N; Fountoulakis M; Lubec G
Electrophoresis; 2001 Apr; 22(6):1233-41. PubMed ID: 11358150
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the relation of herpes simplex virus type 1 to Down syndrome and Alzheimer's disease.
Cheon MS; Bajo M; Gulesserian T; Cairns N; Lubec G
Electrophoresis; 2001 Feb; 22(3):445-8. PubMed ID: 11258753
[TBL] [Abstract][Full Text] [Related]
9. Proteomic signatures and aberrations of mouse embryonic stem cells containing a single human chromosome 21 in neuronal differentiation: an in vitro model of Down syndrome.
Kadota M; Nishigaki R; Wang CC; Toda T; Shirayoshi Y; Inoue T; Gojobori T; Ikeo K; Rogers MS; Oshimura M
Neuroscience; 2004; 129(2):325-35. PubMed ID: 15501590
[TBL] [Abstract][Full Text] [Related]
10. Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain.
Su JH; Kesslak JP; Head E; Cotman CW
Acta Neuropathol; 2002 Jul; 104(1):1-6. PubMed ID: 12070657
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS
Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391
[TBL] [Abstract][Full Text] [Related]
12. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
Albasanz JL; Dalfó E; Ferrer I; Martín M
Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
14. Increased phosphoglycerate kinase in the brains of patients with Down's syndrome but not with Alzheimer's disease.
Labudova O; Kitzmueller E; Rink H; Cairns N; Lubec G
Clin Sci (Lond); 1999 Mar; 96(3):279-85. PubMed ID: 10029564
[TBL] [Abstract][Full Text] [Related]
15. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.
Cataldo AM; Petanceska S; Terio NB; Peterhoff CM; Durham R; Mercken M; Mehta PD; Buxbaum J; Haroutunian V; Nixon RA
Neurobiol Aging; 2004; 25(10):1263-72. PubMed ID: 15465622
[TBL] [Abstract][Full Text] [Related]
16. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome.
Head E; Azizeh BY; Lott IT; Tenner AJ; Cotman CW; Cribbs DH
Neurobiol Dis; 2001 Apr; 8(2):252-65. PubMed ID: 11300721
[TBL] [Abstract][Full Text] [Related]
17. Molecular misreading: the frequency of dinucleotide deletions in neuronal mRNAs for beta-amyloid precursor protein and ubiquitin B.
Gerez L; de Haan A; Hol EM; Fischer DF; van Leeuwen FW; van Steeg H; Benne R
Neurobiol Aging; 2005 Feb; 26(2):145-55. PubMed ID: 15582744
[TBL] [Abstract][Full Text] [Related]
18. Neuroanatomy of Down syndrome in vivo: a model of preclinical Alzheimer's disease.
Teipel SJ; Hampel H
Behav Genet; 2006 May; 36(3):405-15. PubMed ID: 16485178
[TBL] [Abstract][Full Text] [Related]
19. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
Mehta PD; Capone G; Jewell A; Freedland RL
J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
[TBL] [Abstract][Full Text] [Related]
20. Increased protein levels of serotonin transporter in frontal cortex of patients with Down syndrome.
Gulesserian T; Engidawork E; Cairns N; Lubec G
Neurosci Lett; 2000 Dec; 296(1):53-7. PubMed ID: 11099832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]